• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OPT 0.00% 74.0¢

OPTHEA LIMITED

Opthea Limited is an Australia-based biotechnology company. The Company is engaged in the... Opthea Limited is an Australia-based biotechnology company. The Company is engaged in the development and commercialization of therapies primarily for eye disease. The Company’s lead asset, OPT-302, is a novel biologic inhibitor of VEGF-C and VEGF-D, for use in combination with VEGF-A inhibitors for the treatment of wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). The Company’s principal activities include the progression of the Company’s Phase III registration trials of OPT-302 for wet AMD. It also manufactures OPT-302 for use in Phase III clinical trials, conducts activities to support the commercialization of the product and expanded its management team in the United States to facilitate broader oversight and execution of its Phase III program. The Company’s development activities are based on an intellectual property portfolio covering key targets (Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
OPT 28/03/24 30 10K
28/03/24 Last post  Lectroid Comments Created with Sketch.  30  Views Created with Sketch.  10K 
OPT
Opthea Chart
4 5 6
26/03/24 308 165K
26/03/24 Last post  SteelDragon Comments Created with Sketch.  308  Views Created with Sketch.  165K 
OPT 19/03/24 0 314
19/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  314 
OPT 06/03/24 0 297
06/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  297 
OPT
Hang in there!!
2
02/03/24 113 54K
02/03/24 Last post  gmutton Comments Created with Sketch.  113  Views Created with Sketch.  54K 
OPT 02/03/24 6 1.5K
02/03/24 Last post  yehudi Comments Created with Sketch.  6  Views Created with Sketch.  1.5K 
OPT 01/03/24 12 2.7K
01/03/24 Last post  PigRace Comments Created with Sketch.  12  Views Created with Sketch.  2.7K 
OPT 01/03/24 4 857
01/03/24 Last post  Davisite Comments Created with Sketch.  4  Views Created with Sketch.  857 

See All Discussions arrow Created with Sketch.

Timeline

Opthea to Host Key Opinion Leader Event on April 3, 2024
19 Mar 11:50
 
Opthea to Participate in Leerink Global Biopharma Conference
06 Mar 08:19
 
Opthea Corporate Presentation - March 2024
04 Mar 11:51
 
Change of Director's Interest Notice Update
01 Mar 10:20
 
Change of Director's Interest Notice
01 Mar 09:52
 
Opthea Reports Half-Year Results and Business Update
29 Feb 09:07
 
View More arrow Created with Sketch.
(20min delay)
Last
74.0¢
Change
0.000(0.00%)
Mkt cap ! $490.4M
Open High Low Value Volume
76.0¢ 78.8¢ 74.0¢ $2.249M 3.013M

Buyers (Bids)

No. Vol. Price($)
3 65881 72.0¢
 

Sellers (Offers)

Price($) Vol. No.
80.0¢ 12234 2
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
75.0¢
  Change
0.000 ( 0.07 %)
Open High Low Volume
76.0¢ 78.5¢ 74.5¢ 235028
Last updated 15.59pm 29/03/2024 ?
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.